Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Capsensixx AG has the Profitability Rank of 9. It has a higher profitability and may stay that way.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is rated on a scale of 1 to 10 and is based on these factors:
1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank
A higher score indicates superior profitability, with companies rated 7 or above considered to have more robust and sustainable profit generation. Conversely, a score of 3 or lower suggests challenges in generating consistent profits.
FRA:CPX vs BLK, BX, KKR: Profitability Rank Comparison
For the Asset Management subindustry, Capsensixx AG's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Capsensixx AG Profitability Rank vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Capsensixx AG's Profitability Rank distribution charts can be found below:
* The bar in red indicates where Capsensixx AG's Profitability Rank falls into.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
The rank is rated on a scale of 1 to 10. A higher score indicates superior profitability, with companies rated 7 or above considered to have more robust and sustainable profit generation. Conversely, a score of 3 or lower suggests challenges in generating consistent profits.
Capsensixx AG has the Profitability Rank of 9. It has a higher profitability and may stay that way.
Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Capsensixx AG (FRA:CPX) has a Profitability Rank of 9 as of Dec. 2025. Profitability and Growth ranks a company based on its profit margins and earnings growth. View historical data on Capsensixx AG and its competitors. This is 29% above median its historical median of 7.00. Over the past decade, Capsensixx AG's Profitability Rank has ranged from 4.00 to 9.00.
Is Capsensixx AG's Profitability Rank too high?
Capsensixx AG's current Profitability Rank of 9 is 29% above median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 9.00. Overall, Capsensixx AG has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Capsensixx AG's Profitability Rank compare to BLK and BX?
Capsensixx AG's Profitability Rank of 9 can be compared against companies in the Asset Management industry. Historically, Capsensixx AG's own Profitability Rank has ranged from 4.00 to 9.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Profitability Rank for an Asset Management company?
A good Profitability Rank depends on the Asset Management industry context. However, Profitability Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Profitability Rank mean?
A high Profitability Rank can signal that a stock is expensive relative to its fundamentals. Profitability and Growth ranks a company based on its profit margins and earnings growth. View historical data on Capsensixx AG and its competitors. Capsensixx AG's current Profitability Rank is 9, which is 29% above median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Capsensixx AG stock overvalued right now?
Based on GuruFocus' analysis, Capsensixx AG (FRA:CPX) is currently considered Modestly Undervalued. The stock's GF Value™ is €27.91, compared to a current price of €21.00 — trading 24.8% below its estimated fair value. The current Profitability Rank is 9, which is 29% above median its 10-year median of 7.00. Capsensixx AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Profitability Rank calculated?
Profitability Rank is calculated from a company's financial statements. For Capsensixx AG (FRA:CPX), the current Profitability Rank is 9 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Capsensixx AG (FRA:CPX) Overvalued in 2026?
Based on GuruFocus' analysis, Capsensixx AG stock appears to be undervalued.
The current stock price of €21.00 is trading 24.8% below its estimated GF Value™ of €27.91.
GuruFocus considers Capsensixx AG to be Modestly Undervalued.
Key valuation signals for FRA:CPX:
Profitability Rank: 9 (29% above median its 10-year median of 7.00)
GF Value™: €27.91 vs. price of €21.00 (24.8% below fair value)
No single metric tells the full story. See the FRA:CPX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Capsensixx AG is a provider of financial administration as a service. The company is divided into two segments namely Funds management, Administration and Accounting Segment which includes fund management and fund accounting; and Securitisations which provides Advisory services in the field of financial engineering, securitisation and provision of director and administrative services to corporate clients in Luxembourg.
88GF Score
Get the complete analysis for FRA:CPX
Profitability Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:CPX has been successfully added to your 
